首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Identification of CRIP1 as 8.4 kDa Cytosolic Biomarker for the Classification of HER2 Receptor Status in Breast Cancer Tissues

【24h】

Identification of CRIP1 as 8.4 kDa Cytosolic Biomarker for the Classification of HER2 Receptor Status in Breast Cancer Tissues

机译：鉴定乳腺癌组织中HER2受体状态分类的CRIP1至8.4 kda细胞溶质生物标志物

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

A new 8.4 kDa biomarker candidate for HER2-positive breast cancer, the cytosolic protein CRIP1 was established by High Definition MALDI Imaging and Top-Down protein ID using ETD/PTR on an ion trap.

机译：对于HER2阳性乳腺癌的新的8.4 kda生物标志物候选者，在离子阱上使用ETD / PTR的高清MALDI成像和自上而下的蛋白质ID建立了细胞源蛋白CRIP1。

著录项

来源
《American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics 》|2010年||共1页
会议地点
作者
S. Rauser; C. Marquardt; B. Balluff; C. Albers; E. Belau; R. Hartmer; D. Suckau; K. Specht; M.P. Ebert; M. Schmitt; M. Aubele; H. Hofler; A. Walch;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类 TB994.5-53;
关键词

相似文献

外文文献
中文文献
专利

1. Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry [J] . Sandra Rauser, Claudio Marquardt, Benjamin Balluff, Journal of proteome research . 2010 ,第4期

机译：MALDI成像质谱法对乳腺癌组织中HER2受体状态的分类
2. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer. [J] . Muller BM, Kronenwett R, Hennig G, Diagnostic molecular pathology : . 2011 ,第1期

机译：定量测定福尔马林固定石蜡包埋的组织中雌激素受体，孕激素受体和HER2 mRNA-乳腺癌预测生物标志物评估的新选择。
3. Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues [J] . Daniela Berg, Rupert Longer, Kai Tran Axel Walch, Applied immunohistochemistry and molecular morphology: AIMM . 2011 ,第4期

机译：基于蛋白质微阵列的FFPE乳腺癌组织的核心活检和手术标本中HER2，雌激素受体和孕酮受体状态的比较
4. Identification of CRIP1 as 8.4 kDa Cytosolic Biomarker for the Classification of HER2 Receptor Status in Breast Cancer Tissues [C] . S. Rauser, C. Marquardt, B. Balluff, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：鉴定乳腺癌组织中HER2受体状态分类的CRIP1至8.4 kda细胞溶质生物标志物
5. Hormonal exposures and breast cancer characterized by estrogen receptor and progesterone receptor status and Her2/neu oncogene amplification. [D] . Huang, Wen-Yi. 1998

机译：以雌激素受体和孕激素受体状态以及Her2 / neu癌基因扩增为特征的激素暴露和乳腺癌。
6. Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry [O] . S. Rauser, C. Marquardt, B. Balluff, 2010

机译：MALDI成像质谱法对乳腺癌组织中HER2受体状态的分类
7. Classification of HER2 Receptor Status in Breast Cancer Tissues by MALDI Imaging Mass Spectrometry [O] . Rauser S., Marquardt C., Balluff B., 100

机译：MALDI成像质谱法对乳腺癌组织中HER2受体状态的分类

Identification of CRIP1 as 8.4 kDa Cytosolic Biomarker for the Classification of HER2 Receptor Status in Breast Cancer Tissues

摘要

著录项

相似文献

相关主题

期刊订阅